Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Siegfried Holding AG (SGFEF)
OTHER OTC:SGFEF
RESEARCH TOOLSreports
Holding SGFEF?
Track your performance easily
SGFEF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$837.50 - $1,299.50
Previous Close$1,242.6
Volume80.00
Average Volume (3M)N/A
Market Cap
$5.35B
Enterprise Value$5.25B
Total Cash (Recent Filing)CHF91.62M
Total Debt (Recent Filing)CHF0.00
Price to Earnings (P/E)36.5
Beta0.13
Next Earnings
Feb 18, 2025EPS Estimate
$21.94Last Dividend Ex-Date
May 03, 2024Dividend Yield0.33%
Share Statistics
EPS (TTM)34.02
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.18
R-Squared0.09
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.37
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,327.69Price Target Upside37.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Financial OutlookAnalyst's recommendation has been updated to Buy due to a compelling risk/reward scenario.
Market Performance1H24 beat expectations by 2/3.5%, underscoring Siegfried's robust underlying market growth.
Strategic DevelopmentsThe SFZN CMD should be comforting to investors as the presented EVOLVE+ strategy and CEO hit the right notes.
Bears Say
Growth VectorsVectors for accelerating growth such as new technologies and M&A in Biologics or fill & finish are present but just not overly evident.
ProfitabilitySFZN will have to target small- and mid-sized pharma for incremental contracts, raising questions about the profitability of producing smaller sales drugs.
Revenue ChallengesLack of Novavax revenues in 2024 and destocking across '23/'24 are expected to be headwinds.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.87% Mutual Funds
― Other Institutional Investors
87.98% Public Companies and
Individual Investors
SGFEF FAQ
What was Siegfried Holding AG’s price range in the past 12 months?
Siegfried Holding AG lowest stock price was $837.50 and its highest was $1299.50 in the past 12 months.
What is Siegfried Holding AG’s market cap?
Currently, no data Available
When is Siegfried Holding AG’s upcoming earnings report date?
Siegfried Holding AG’s upcoming earnings report date is Feb 18, 2025 which is in 83 days.
How were Siegfried Holding AG’s earnings last quarter?
Siegfried Holding AG released its earnings results on Aug 22, 2024. The company reported $18.887 earnings per share for the quarter, beating the consensus estimate of $17.377 by $1.509.
Is Siegfried Holding AG overvalued?
According to Wall Street analysts Siegfried Holding AG’s price is currently Undervalued.
Does Siegfried Holding AG pay dividends?
Siegfried Holding AG pays a Annually dividend of $4.08 which represents an annual dividend yield of 0.33%. See more information on Siegfried Holding AG dividends here
What is Siegfried Holding AG’s EPS estimate?
Siegfried Holding AG’s EPS estimate is $21.94.
How many shares outstanding does Siegfried Holding AG have?
Siegfried Holding AG has 4,513,000 shares outstanding.
What happened to Siegfried Holding AG’s price movement after its last earnings report?
Siegfried Holding AG reported an EPS of $18.887 in its last earnings report, beating expectations of $17.377. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Siegfried Holding AG?
Currently, no hedge funds are holding shares in SGFEF
---
Siegfried Holding AG Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.87%
12-Months-Change
Fundamentals
Return on Equity
16.36%
Trailing 12-Months
Asset Growth
5.74%
Trailing 12-Months
Company Description
Siegfried Holding AG
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.
---
SGFEF Company Deck
---
SGFEF Earnings Call
Q2 2024
0:00 / 0:00
---
SGFEF Stock 12 Month Forecast
Average Price Target
$1,327.69
▲(37.58% Upside)
Technical Analysis
Best Analysts Covering SGFEF
1 Year
1 Year Success Rate
3/3 ratings generated profit
1 Year Average Return
+30.40%
reiterated a buy rating 3 months ago
Copying Fynn Scherzler's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +30.40% per trade.
---